Furthermore, the pMMR cohort was older (P = 0.032), had higher CRP values (P < 0.001), higher ALB (albumin) (P = 0.005), non-adenocarcinoma (P = 0.010), advanced stage cancer (P = 0.004), had RCC primary tumors (P < 0.001), TLN (Total lymph node) > 12 (P < 0.001), vascular invasion (P = 0.030), and had been treated with chemotherapy (P = 0.001). This evidence concerns the gene ALB and adenocarcinoma.